Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 18, 2011Microcirculation

A Human Neutralizing Antibody Specific to Ang‐2 Inhibits Ocular Angiogenesis

View Full Paper
Ask AI
Bookmark
Share

Authors

EREmma RennelOlink Bioscience (Sweden)JRJörg T. RegulaRoche Pharma AG (Germany)SHSteven J. HarperNorth Bristol NHS Trust

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rennel et al. (2011) studied this question.

synapsesocial.com/papers/6a7ff20004731064ad46f268https://doi.org/10.1111/j.1549-8719.2011.00120.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Phase 1 Study of AMG 386, a Selective Angiopoietin 1/2–Neutralizing Peptibody, in Combination with Chemotherapy in Adults with Advanced Solid Tumors2010 · 101 citations
  2. 2Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling2005 · 373 citations
  3. 3Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival <i>in vivo</i>2002 · 672 citations
  4. 4Complementary Actions of Inhibitors of Angiopoietin-2 and VEGF on Tumor Angiogenesis and Growth2010 · 250 citations
  5. 5Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting,during a critical developmental period2005 · 106 citations